Biogen Idec announces plans to build factory north of Copenhagen  

The US biotech company has announced plans to build a new factory in Hillerød for production of a new treatment for MS

US biotech company Biogen Idec has announced plans to build a new factory for production of a new treatment for multiple sclerosis (MS) in Hillerød north of Copenhagen, a part of Medicon Valley. Biogen says that construction of the factory will commence as soon as possible. The construction budget is around DKK 2 billion (USD 320 million) and 200 new jobs are expected to be created when production starts up in 2008.


A year ago Biogen shelved similar plans for building a factory in Hillerød when it merged with IDEC Pharmaceuticals Corporation into Biogen Idec. At the time Idec was already constructing a factory for production of a treatment for MS in the US which put a stop to Biogen's plans in Hillerød.


Biogen Idec is headquartered in Cambridge, MA and currently employs 4,000 people worldwide. Biogen Idec has a pipeline of 10 products in clinical development, one of which is the new treatment for MS and Crohn's disease – Antegren – the drug expected to be produced in Hillerød. The news is reported by regional newspaper Frederiksborg Amts Avis.

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×